These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25418440)

  • 1. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Rodeberg DA; Wharam MD; Lyden ER; Stoner JA; Brown K; Wolden SL; Paidas CN; Donaldson SS; Hawkins DS; Spunt SL; Arndt CA
    Int J Cancer; 2015 Jul; 137(1):204-11. PubMed ID: 25418440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
    Lautz TB; Chi YY; Li M; Wolden SL; Casey DL; Routh JC; Granberg CF; Binite O; Rudzinski ER; Hawkins DS; Venkatramani R; Rodeberg DA
    Cancer; 2021 Jan; 127(2):275-283. PubMed ID: 33079399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
    Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
    Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients.
    Regine WF; Fontanesi J; Kumar P; Ayers D; Bowman LC; Pappo AS; Coffey DH; Avery L; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):485-91. PubMed ID: 7852110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.
    Aye JM; Xue W; Palmer JD; Walterhouse DO; Arnold MA; Heaton TE; Venkatramani R
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28914. PubMed ID: 33501771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88.
    Cecchetto G; Carli M; Sotti G; Bisogno G; Dall'Igna P; Boglino C; Granata C; Antoniello L; Guglielmi M
    Med Pediatr Oncol; 2000 Feb; 34(2):97-101. PubMed ID: 10657868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.
    Casey DL; Wexler LH; LaQuaglia MP; Meyers PA; Wolden SL
    Pediatr Blood Cancer; 2014 Sep; 61(9):1565-9. PubMed ID: 24798662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas: results of CWS 81 and 86 studies].
    Koscielniak E; Herbst M; Niethammer D; Treuner J
    Klin Padiatr; 1994; 206(4):269-76. PubMed ID: 7967423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
    Breneman J; Meza J; Donaldson SS; Raney RB; Wolden S; Michalski J; Laurie F; Rodeberg DA; Meyer W; Walterhouse D; Hawkins DS
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):720-6. PubMed ID: 22104356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
    Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
    Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.
    Casey DL; Chi YY; Donaldson SS; Hawkins DS; Tian J; Arndt CA; Rodeberg DA; Routh JC; Lautz TB; Gupta AA; Yock TI; Wolden SL
    Cancer; 2019 Sep; 125(18):3242-3248. PubMed ID: 31174239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
    J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma.
    Yang JC; Dharmarajan KV; Wexler LH; La Quaglia MP; Happersett L; Wolden SL
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e371-7. PubMed ID: 22658517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
    Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
    Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
    Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.